NEW YORK (AP) â¿¿ Shares of medical device companies were mostly lower Thursday after the Supreme Court upheld the 2010 health care overhaul law.
In a highly anticipated decision, the court ruled the health care law is Constitutional by a 5-4 majority. The vote upheld almost the entire the law, including a provision that requires most people to have health insurance or will have to pay a fine.
FBR Capital Markets analyst Benjamin Salisbury said the ruling was a surprise because many people expected the insurance mandate to be overturned. He said the ruling "is likely to be viewed most negatively for medical device manufacturers" because the law includes an excise tax on medical devices that goes into effect in January.
President Obama signed the Patient Protection and Affordable Care Act in to law in March 2010 after a year of intense national debate. The law allows children to remain on their parents' insurance until the child turns 26, bars health insurers from dropping plan members who became ill, prohibits insurers from excluding children under 19 who had pre-existing health problems, requires insurer to spend certain percentages of their premium dollars on medical care, and authorizes the Food and Drug Administration to approve generic versions of biotech drugsParts of the law are still being phased in. By 2014, health insurers will not be allowed to exclude people to people with pre-existing health problems or make them pay higher rates and people will be allowed to buy health insurance through exchanges. Also influencing the market for medical device makers is a hearing by a panel of experts with the Food and Drug Administration on the safety of metal-on-metal replacement hip implants. They're weighing growing evidence that the devices can break down earlier and expose patients to dangerous metallic particles. In morning trading, shares of Medtronic Inc. added 42 cents to $37.49, while St. Jude Medical Inc. stock lost 38 cents to $38.26 and Boston Scientific Corp. shares fell 13 cents, or 2.3 percent, to $5.51. Stryker Corp. fell $1.24, or 2.3 percent, to $53.09.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV